HAC (Russian)
RSCI (Russian)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services


Download full text PDF

A. Kudryavtseva, MD; A. Mingaliev; E. Neskorodova I.M. Sechenov First Moscow State Medical University, Moscow

Atopic dermatitis is a chronic continuously recurrent skin disease with early onset. Nowadays the pathogenesis of many local inflammatory processes is studied rather well and diagnostic and treatment techniques are thoroughly worked out. However, in a number of cases the disease still progresses: the periods of short remission are followed by flare-ups. Why do we sometimes fail to induce longlasing remission? What causes severe AD? We have tried to answer these and some other questions by analyzing recommended and applied treatment methods and employing Russian and foreign professional publications. We have proved that anti-relapse therapy supported with the usage of cosmetics gives assurance in AD effective treatment.

atopic dermatitis
severe form
cyclosporine A
external therapy
antihistaminic agents

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

  1. Perlamutrov Ju.N., Kljuchnikova D.E. Osobennosti techenija atopicheskogo dermatita u detej, postojanno prozhivajuschih v uslovijah antopogennogo zagrjaznenija // Vestn. dermatol. venerol. – 2011; 5: 102–7
  2. Burrenl-Morris C., Williams H. Atopic dermatitis in migrant population. Atopic dermatitis. The epidemiology, causes and prevention of atopic eczema / Cambridge, MA, 2000; 228 p.
  3. Kudrjavtseva A.V., Makarova S.G. Sluchaj tjazhelogo techenija atopicheskogo dermatita u rebenka rannego vozrasta // Vopr. praktich. pediatrii. – 2010; 4 (5): 18–21.
  4. Bikowski J., Pillai R., Shroot B. The position not the presence of the halogen in corticosteroids influences potency and side effects // J. Drugs Dermatol. – 2006; 5 (2): 125–30.
  5. Pallen A., Lebwohl M., Fleischer A. et al. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies // J. Am. Acad. Dermatol. – 2005; 52 (5): 810–22.
  6. Sidbury R., Davis D., Cohen D. et al. Guidelines of care for the management of atopic dermatitis: section 2 and 3. Management and treatment of atopic dermatitis with topical therapies. Management and treatment with phototherapy and systemic agents // J. Am. Acad. Dermatol. – 2014; 71 (1, 2): 327–49.
  7. Hung S., Lin Y., Chu C. et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics // Ann. Allergy Asthma Immunol. – 2007; 98 (1): 51–6.
  8. Atopicheskij dermatit u detej: diagnostika, lechenie i profilaktika: Nauchno-praktich. programma / M., 2000; 76 s.
  9. Wahlgren C., Hagermark O., Bergstrom R. The antipruritis effect of a sedative and a non-sedative antihistamine in atopic dermatitis // Br. J. Dermatol. – 1990; 122: 545–51.
  10. Greene R., Winkermann R. Opfer-Gehrking T. Sweeting patterns in atopic dermatitis patients // Arch. Dermatol. Res. – 1989; 281: 373–6.
  11. Soncoly E., Muller A., Lauerma A. et al. IL-31: A new link between T cells and pruritus in atopic skin inflammation // J. Allergy Clin. Immunol. – 2006; 117: 411–7.
  12. Toropina G.G., Judina M.M., L'vov A.N. i dr. Nejrofiziologicheskie mehanizmy zuda pri atopicheskom dermatite: issledovanie dlinnolatentnyh vyzvannyh potentsialov na termicheskuju stimuljatsiju tonkih volokon // Ros. zhurn. kozhnyh i venericheskih boleznej. – 2008; 4: 18–22.
  13. Michenko A.V., L'vov A.N., Ivanov O.L. i dr. Psihosomaticheskie aspekty atopicheskogo dermatita: klassicheskie kanony i novye predstavlenija // Ros. zhurn. kozhnyh i venericheskih boleznej. – 2008; 4: 11–8.
  14. Yoshihara K. Psychosomatic treatment for allergic diseases // Biopsychosoc. Med. – 2015; 18 (9): 8.
  15. Warner J. ETAC Study Group. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months`treatment and 18 months`posttreatment follow-up // J. Allergy Clin. Immunol. – 2001; 108: 929–37.
  16. Kudrjavtseva A.V., Vozmozhnosti terapii tjazhelyh form atopicheskogo dermatita u detej i podrostkov // Vopr. praktich. pediatrii. – 2011; 6 (6): 51–6.
  17. Kochergin N.G., Potekaev N.S. Tsiklosporin A pri atopicheskom dermatite / M., 1999; 24 s.